Whole genome sequencing for improved understanding of Mycobacterium tuberculosis transmission in a remote circumpolar region.


Journal

Epidemiology and infection
ISSN: 1469-4409
Titre abrégé: Epidemiol Infect
Pays: England
ID NLM: 8703737

Informations de publication

Date de publication:
01 2019
Historique:
entrez: 1 8 2019
pubmed: 1 8 2019
medline: 28 3 2020
Statut: ppublish

Résumé

Few studies have used genomic epidemiology to understand tuberculosis (TB) transmission in rural and remote settings - regions often unique in history, geography and demographics. To improve our understanding of TB transmission dynamics in Yukon Territory (YT), a circumpolar Canadian territory, we conducted a retrospective analysis in which we combined epidemiological data collected through routine contact investigations with clinical and laboratory results. Mycobacterium tuberculosis isolates from all culture-confirmed TB cases in YT (2005-2014) were genotyped using 24-locus Mycobacterial Interspersed Repetitive Units-Variable Number of Tandem Repeats (MIRU-VNTR) and compared to each other and to those from the neighbouring province of British Columbia (BC). Whole genome sequencing (WGS) of genotypically clustered isolates revealed three sustained transmission networks within YT, two of which also involved BC isolates. While each network had distinct characteristics, all had at least one individual acting as the probable source of three or more culture-positive cases. Overall, WGS revealed that TB transmission dynamics in YT are distinct from patterns of spread in other, more remote Northern Canadian regions, and that the combination of WGS and epidemiological data can provide actionable information to local public health teams.

Identifiants

pubmed: 31364521
pii: S0950268819000670
doi: 10.1017/S0950268819000670
pmc: PMC6518594
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e188

Références

N Engl J Med. 2011 Feb 24;364(8):730-9
pubmed: 21345102
Clin Infect Dis. 2018 Mar 5;66(6):849-856
pubmed: 29069284
BMC Med. 2017 Jun 13;15(1):105
pubmed: 28606177
J Infect Dis. 2017 Nov 3;216(suppl_6):S644-S653
pubmed: 29112745
J Infect Dis. 2015 Jun 15;211(12):1905-14
pubmed: 25576599
Clin Microbiol Rev. 2015 Apr;28(2):523-39
pubmed: 25810419
Int J Tuberc Lung Dis. 2009 Jan;13(1):17-26
pubmed: 19105874
N Engl J Med. 2018 Oct 11;379(15):1403-1415
pubmed: 30280646
PLoS Med. 2013;10(2):e1001387
pubmed: 23424287
Int J Infect Dis. 2011 Aug;15(8):e510-3
pubmed: 21737332
Clin Infect Dis. 1995 Nov;21(5):1170-4
pubmed: 8589138
PLoS One. 2014 Nov 18;9(11):e112928
pubmed: 25405861
Lancet Infect Dis. 2013 Feb;13(2):137-46
pubmed: 23158499
PLoS One. 2012;7(7):e41253
pubmed: 22911768
Lancet Infect Dis. 2014 May;14(5):406-15
pubmed: 24602842
Sci Rep. 2016 Sep 12;6:33180
pubmed: 27615360
Lancet Infect Dis. 2015 Oct;15(10):1193-1202
pubmed: 26116186
Lancet Public Health. 2018 Mar;3(3):e133-e142
pubmed: 29426597
PLoS One. 2013 Jun 27;8(6):e67516
pubmed: 23826313
Can Commun Dis Rep. 2018 Mar 01;44(3-4):75-81
pubmed: 31007614
Int J Tuberc Lung Dis. 2018 Jun 1;22(6):641-648
pubmed: 29862948
Lancet Respir Med. 2014 Apr;2(4):285-292
pubmed: 24717625

Auteurs

J L Guthrie (JL)

School of Population and Public Health,University of British Columbia,Vancouver,Canada.

L Strudwick (L)

Yukon Communicable Disease Control,Health and Social Services,Government of Yukon,Whitehorse,Canada.

B Roberts (B)

Yukon Communicable Disease Control,Health and Social Services,Government of Yukon,Whitehorse,Canada.

M Allen (M)

Yukon Communicable Disease Control,Health and Social Services,Government of Yukon,Whitehorse,Canada.

J McFadzen (J)

Yukon Communicable Disease Control,Health and Social Services,Government of Yukon,Whitehorse,Canada.

D Roth (D)

British Columbia Centre for Disease Control,Vancouver,Canada.

D Jorgensen (D)

British Columbia Centre for Disease Control,Public Health Laboratory,Vancouver,Canada.

M Rodrigues (M)

British Columbia Centre for Disease Control,Public Health Laboratory,Vancouver,Canada.

P Tang (P)

Department of Pathology,Sidra Medical and Research Center,Doha,Qatar.

B Hanley (B)

Department of Health and Social Services,Government of Yukon,Whitehorse,Canada.

J Johnston (J)

British Columbia Centre for Disease Control,Vancouver,Canada.

V J Cook (VJ)

British Columbia Centre for Disease Control,Vancouver,Canada.

J L Gardy (JL)

School of Population and Public Health,University of British Columbia,Vancouver,Canada.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH